via aws.amazon.com => original post link
From population sequencing, to drug discovery, to diagnostics research, omics data is driving a deeper understanding and personalization in how healthcare is delivered. While the value of multi-omics data is understood, our healthcare and life sciences (HCLS) customers want better tools to get started, build applications, and scale up analyses that will help lower costs and accelerate insights.
We launched AWS HealthOmics at re:Invent 2022 to help HCLS organizations build at-scale to store, query, and analyze genomic, transcriptomic, proteomic, and other omics data. We’ve already seen customers and partners adopt HealthOmics to store omics data and run bioinformatics analysis pipelines at production scale while spending less time managing infrastructure.